Project
SAKK 07/17
Ongoing - recruitment closed · 2018 until 2099
Aeppli Stefanie, Breuss Kim, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2018
End Date
2099
Financing
SAKK
Labels
kidney cancer
Brief description/objective
Nivolumab in combination with Ipilimumab in patients with metastatic renal cell carcinoma: A multicentre single-arm phase lI trial.